C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 120 filers reported holding C4 THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $13 | -56.7% | 4,184 | -18.9% | 0.00% | – |
| Q4 2022 | $30 | -99.9% | 5,159 | 0.0% | 0.00% | – |
| Q3 2022 | $45,000 | +15.4% | 5,159 | 0.0% | 0.00% | – |
| Q2 2022 | $39,000 | -74.5% | 5,159 | -18.0% | 0.00% | -100.0% |
| Q1 2022 | $153,000 | -65.1% | 6,290 | -53.7% | 0.00% | -50.0% |
| Q4 2021 | $438,000 | +42.7% | 13,598 | +98.1% | 0.00% | -33.3% |
| Q3 2021 | $307,000 | +24.8% | 6,864 | +5.5% | 0.00% | +50.0% |
| Q2 2021 | $246,000 | – | 6,504 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 481,094 | $21,495,000 | 5.67% |
| Soleus Capital Management, L.P. | 750,633 | $33,538,000 | 5.23% |
| Bain Capital Life Sciences Investors, LLC | 1,642,209 | $73,374,000 | 4.55% |
| RTW INVESTMENTS, LP | 2,494,965 | $111,475,000 | 1.68% |
| P.A.W. CAPITAL CORP | 40,000 | $1,787,000 | 1.59% |
| Perceptive Advisors | 2,258,566 | $100,913,000 | 1.47% |
| SPHERA FUNDS MANAGEMENT LTD. | 381,774 | $17,058,000 | 1.43% |
| CLOUGH CAPITAL PARTNERS L P | 347,500 | $15,526,000 | 0.94% |
| HighVista Strategies LLC | 29,341 | $1,311,000 | 0.87% |
| RA Capital Management | 1,377,569 | $61,550,000 | 0.85% |